MLH1 and breast cancer: Accumulating data on these methylation markers including the six genes tested in this study (HOXD13, SFN, RASSF1a, P16, PCDHGB7, and hMLH1) is of interest for further evaluation as serum- or serum-based biomarkers for the detection and monitoring of breast cancer patients.